Dark

OVID
Ovid Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Apr 17, 2026 3:59:59 PM EDT

2.91USD+3.929%(+0.11)2,372,733

2.45Bid 3.33Ask 0.88Spread

Pre-market

Apr 17, 2026 9:26:30 AM EDT

2.85USD+1.743%(+0.05)121,735

After-hours

Apr 17, 2026 4:53:30 PM EDT

2.90USD-0.344%(-0.01)1,649

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

439.49M

CEO

Jeremy Levin

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

May 12, 2026 (24d)

OMER XLV

OVID Stats

Avg. Vol. 10 Day

4,306,635

Avg. Vol. 30 Day

4,796,830

Employees

Market Cap

439,494,259

Shares Out.

151,028,955

On/Off Exchange

52%/48%

6 Month Beta

1.72

1 Year Beta

1.45

2 Year Beta

1.39

3 Year Beta

1.31

52 Week Low

0.27

52 Week High

3.11

SMA50

2.03

SMA200

1.46

1 Week

+5.82%

1 Month

+44.78%

3 Month

+85.35%

6 Month

+96.62%

1 Year

+908.32%

2 Year

-6.43%

5 Year

-23.02%

Profile

ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid's drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/

OVID Stock Summary

Ovid Therapeutics Inc. Common Stock (NASDAQ:OVID) stock price today is $2.91, and today's volume is 2,372,733. OVID is up 3.929% today. The 30 day average volume is 4,796,830. OVID market cap is 439.49M with 151,028,955 shares outstanding.